Minerva Neurosciences Inc
NERV
Get informed when a big investor buys or sells
+ FollowMarket Cap$170.51M
Close$
$2.05
40.6% downside
Current Fair Value
40.6% downsideOvervalued by 40.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $170.51 Million |
|---|---|
| Enterprise Value | $-24,481,571,358.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-34.67 |
| Beta | -0.11 |
| Outstanding Shares | 46,599,044 |
Return
| Return on Equity | 1415.46% |
|---|---|
| Return on Assets | -3000.34% |
| Return on Invested Capital | -3151.15% |
Valuation & Multiples
| P/E Ratio | -0.13 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 91.06%▲ 3.82% |
|---|---|
| Total Invested | $235.45M▲ 2.02% |
| Investors Holding | 59▲ 15.00% |
ESG Score
No data
About Minerva Neurosciences Inc
CEO: Remy Luthringer